With this year’s review of the State of New Jersey’s life sciences industry, BioNJ expands on its remit of prior years by assessing the three major sectors that make up New Jersey’s life sciences innovation cluster: biotechnology, pharmaceuticals, and medical devices.
The report also is meant to rebut Ben Franklin’s infamous pronouncement that New Jersey is “a barrel tapped at both ends”. All too often reports analyzing the life sciences industry have followed Franklin’s notion by dividing New Jersey along the metropolitan statistical area (MSA) boundaries of New York/Northern New Jersey and the Delaware Valley which incorporates southern New Jersey.
